Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.

Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...

A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...

The CBSE noted a significant increase in Type-2 diabetes among children over the past decade, adding that sugar constitutes ...

Growing demand for natural weight loss solutions drives the weight management supplements market across health-conscious consumer segments.

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

I read an article a few years back that said if you had vertigo, you more than likely would also have restless legs syndrome ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending flexibilities for compounded products. The grace period for manufacturers to ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but ...